IFP Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-240
| Closed | -$45K | – | 5106 |
|
|
2021
Q2 | $45K | Buy |
240
+23
| +11% | +$3.95K | ﹤0.01% | 1576 |
|
|
2021
Q1 | $32K | Sell |
217
-43
| -17% | -$6.65K | ﹤0.01% | 1640 |
|
|
2020
Q4 | $40K | Sell |
260
-1
| -0.4% | -$129 | ﹤0.01% | 1531 |
|
|
2020
Q3 | $30K | Sell |
261
-37
| -12% | -$3.99K | ﹤0.01% | 1484 |
|
|
2020
Q2 | $33K | Sell |
298
-13
| -4% | -$1.38K | ﹤0.01% | 1390 |
|
|
2020
Q1 | $26K | Buy |
311
+7
| +2% | +$687 | ﹤0.01% | 1392 |
|
|
2019
Q4 | $32K | Buy |
304
+54
| +22% | +$5.78K | ﹤0.01% | 1435 |
|
|
2019
Q3 | $24K | Buy |
+250
| New | +$28.2K | ﹤0.01% | 1700 |
|
|
2019
Q1 | $4K | Sell |
34
-318
| -90% | -$39.5K | ﹤0.01% | 1962 |
|
|
2018
Q4 | $34K | Buy |
352
+79
| +29% | +$9.34K | ﹤0.01% | 1836 |
|
|
2018
Q3 | $38K | Sell |
273
-41
| -13% | -$5.14K | ﹤0.01% | 2054 |
|
|
2018
Q2 | $39K | Sell |
314
-484
| -61% | -$56.6K | ﹤0.01% | 2077 |
|
|
2018
Q1 | $95K | Hold |
798
| – | – | ﹤0.01% | 1418 |
|
|
2017
Q4 | $95K | Buy |
798
+154
| +24% | +$18.8K | ﹤0.01% | 1430 |
|
|
2017
Q3 | $90K | Buy |
644
+208
| +48% | +$28.3K | ﹤0.01% | 1621 |
|
|
2017
Q2 | $53K | Sell |
436
-74
| -15% | -$8.61K | ﹤0.01% | 1935 |
|
|
2017
Q1 | $62K | Sell |
510
-17
| -3% | -$2.19K | ﹤0.01% | 1802 |
|
|
2016
Q4 | $64K | Buy |
527
+51
| +11% | +$6.24K | ﹤0.01% | 1742 |
|
|
2016
Q3 | $58K | Buy |
476
+68
| +17% | +$8.75K | ﹤0.01% | 1721 |
|
|
2016
Q2 | $48K | Buy |
408
+374
| +1,100% | +$53.1K | ﹤0.01% | 1791 |
|
|
2016
Q1 | $4K | Sell |
34
-129
| -79% | -$18.9K | ﹤0.01% | 1954 |
|
|
2015
Q4 | $31K | Buy |
+163
| New | +$28.5K | ﹤0.01% | 1900 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM